Diabetes Clinical Trials in Omaha, NE

23 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Blood Markers of Early Pancreas Cancer	—	University of Nebraska	<1 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	<1 mi
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs	N/A	StimLabs	<1 mi
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk	—	Creighton University	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease	N/A	University of Nebraska	<1 mi
Empagliflozin Treatment in Kidney Transplant Recipients	Phase 4	VA Office of Research and Development	<1 mi
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.	Phase 4	Royal Biologics	<1 mi
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity	Phase 3	Pfizer	<1 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin	Phase 3	AstraZeneca	<1 mi
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)	Phase 3	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications	Phase 3	Novo Nordisk A/S	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	18 mi
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus	Phase 2	Hanmi Pharmaceutical Company Limited	32 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	50 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	50 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes	Phase 3	Kailera	50 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.